(Q43663083)

English

Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma

scientific article published in June 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma (English)

1 reference

Europe PubMed Central

25 November 2017

author name string

Arland M

1

1 reference

Europe PubMed Central

25 November 2017

Leuner S

2

1 reference

Europe PubMed Central

25 November 2017

Lange S

3

1 reference

Europe PubMed Central

25 November 2017

Bartsch R

4

1 reference

Europe PubMed Central

25 November 2017

Kahl C

5

1 reference

Europe PubMed Central

25 November 2017

Florschütz A

6

1 reference

Europe PubMed Central

25 November 2017

Franke A

7

1 reference

Europe PubMed Central

25 November 2017

Höffkes HG

8

1 reference

Europe PubMed Central

25 November 2017

publication date

1 June 2001

1 reference

Europe PubMed Central

25 November 2017

Hematological Oncology

1 reference

Europe PubMed Central

25 November 2017

19

1 reference

Europe PubMed Central

25 November 2017

59-66

1 reference

Europe PubMed Central

25 November 2017

2

1 reference

Europe PubMed Central

25 November 2017

The treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Comparative study of peripheral blood progenitor cell collection in patients with multiple myeloma after single-dose cyclophosphamide combined with rhGM-CSF or rhG-CSF.

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF alone.

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections.

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Where do we stand with respect to the use of peripheral blood progenitor cells?

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

GM-CSF for peripheral blood stem cell harvest in myeloma

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1002%2FHON.669

21 January 2018

Identifiers

10.1002/HON.669

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43663083&oldid=2131546159"